Literature DB >> 12663263

Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO.

Kazuyoshi Kirima1, Koichiro Tsuchiya, Hiroyoshi Sei, Toyoshi Hasegawa, Michiyo Shikishima, Yuki Motobayashi, Kyoji Morita, Masanori Yoshizumi, Toshiaki Tamaki.   

Abstract

The measurement of hemoglobin-nitric oxide (NO) adduct (HbNO) in whole blood by the electron paramagnetic resonance (EPR) method seems relevant for the assessment of systemic NO levels. However, ceruloplasmin and unknown radical species overlap the same magnetic field as that of HbNO. To reveal the EPR spectrum of HbNO, we then introduced the EPR signal subtraction method, which is based on the computer-assisted subtraction of the digitized EPR spectrum of HbNO-depleted blood from that of sample blood using the software. Rats were treated with N(omega)-nitro-L-arginine methyl ester (L-NAME; 120 mg. kg-1. day-1) for 1 wk to obtain HbNO-depleted blood. When this method was applied to the analysis of untreated fresh whole blood, the five-coordinate state of HbNO was observed. HbNO concentration in pentobarbital-anesthetized rats was augmented (change in [HbNO] = 1.6-5.5 microM) by infusion of L-arginine (0.2-0.6 g/kg) but not D-arginine. Using this method, we attempted to evaluate the effects of temocapril on HbNO dynamics in an L-NAME-induced rat endothelial dysfunction model. The oral administration of L-NAME for 2 wk induced a serious hypertension, and the HbNO concentration was reduced (change in [HbNO] = 5.7 microM). Coadministration of temocapril dose dependently improved both changes in blood pressure and the systemic HbNO concentration. In this study, we succeeded in measuring the blood HbNO level as an index of NO by the EPR HbNO signal subtraction method. We also demonstrated that temocapril improves abnormalities of NO dynamics in L-NAME-induced endothelial dysfunction rats using the EPR HbNO signal subtraction method.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663263     DOI: 10.1152/ajpheart.01010.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Regulation of nitric oxide consumption by hypoxic red blood cells.

Authors:  Tae H Han; Erion Qamirani; Allyson G Nelson; Daniel R Hyduke; Gautam Chaudhuri; Lih Kuo; James C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

2.  An electron paramagnetic resonance investigation of the oxygen dependence of the arterial-venous gradient of nitrosyl hemoglobin in blood circulation.

Authors:  JinJie Jiang; Jean Corbett; Neil Hogg; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

3.  Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production.

Authors:  Madushi Raththagala; Welivitya Karunarathne; Matthew Kryziniak; John McCracken; Dana M Spence
Journal:  Eur J Pharmacol       Date:  2010-07-23       Impact factor: 4.432

4.  Assessment of nitric oxide signals by triiodide chemiluminescence.

Authors:  Alfred Hausladen; Ruslan Rafikov; Michael Angelo; David J Singel; Evgeny Nudler; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-07       Impact factor: 11.205

Review 5.  Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide.

Authors:  Behrad Derakhshan; Gang Hao; Steven S Gross
Journal:  Cardiovasc Res       Date:  2007-05-03       Impact factor: 10.787

6.  Nitrosylated hemoglobin levels in human venous erythrocytes correlate with vascular endothelial function measured by digital reactive hyperemia.

Authors:  Irina I Lobysheva; Pauline Biller; Bernard Gallez; Christophe Beauloye; Jean-Luc Balligand
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

7.  Nitrosyl-hemoglobin formation in rodent and human venous erythrocytes reflects NO formation from the vasculature in vivo.

Authors:  Flavia Dei Zotti; Irina I Lobysheva; Jean-Luc Balligand
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.